Response to Letter Re: Dose-individualisation of fluoropyrimidines based on pre-treatment serum uracil levels

Niels Heersche; Ron H.J. Mathijssen; Annemieke Cats; Henk Jan Guchelaar; Jonathan E. Knikman

doi:10.1016/j.ejca.2025.115806

Response to Letter Re: Dose-individualisation of fluoropyrimidines based on pre-treatment serum uracil levels

Niels Heersche
, Ron H.J. Mathijssen
, Annemieke Cats
, Henk Jan Guchelaar
, Jonathan E. Knikman^*

^*Corresponding author for this work

Julius Center, dept. Global Public Health & Bioethics

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

Original language	English
Article number	115806
Journal	European Journal of Cancer
Volume	230
DOIs	https://doi.org/10.1016/j.ejca.2025.115806
Publication status	Published - 17 Nov 2025

Access to Document

10.1016/j.ejca.2025.115806

PIIS0959804925005921Final published version, 321 KBLicence: Taverne

Cite this

@article{144e7963fd994489bd38aaeb6172d419,

title = "Response to Letter Re: Dose-individualisation of fluoropyrimidines based on pre-treatment serum uracil levels",

author = "Niels Heersche and Mathijssen, \{Ron H.J.\} and Annemieke Cats and Guchelaar, \{Henk Jan\} and Knikman, \{Jonathan E.\}",

year = "2025",

month = nov,

day = "17",

doi = "10.1016/j.ejca.2025.115806",

language = "English",

volume = "230",

journal = "European Journal of Cancer",

issn = "0959-8049",

publisher = "Elsevier Limited",

}

TY - JOUR

T1 - Response to Letter Re

T2 - Dose-individualisation of fluoropyrimidines based on pre-treatment serum uracil levels

AU - Heersche, Niels

AU - Mathijssen, Ron H.J.

AU - Cats, Annemieke

AU - Guchelaar, Henk Jan

AU - Knikman, Jonathan E.

PY - 2025/11/17

Y1 - 2025/11/17

UR - https://www.scopus.com/pages/publications/105016792795

U2 - 10.1016/j.ejca.2025.115806

DO - 10.1016/j.ejca.2025.115806

M3 - Comment/Letter to the editor

C2 - 41014856

AN - SCOPUS:105016792795

SN - 0959-8049

VL - 230

JO - European Journal of Cancer

JF - European Journal of Cancer

M1 - 115806

ER -

Response to Letter Re: Dose-individualisation of fluoropyrimidines based on pre-treatment serum uracil levels

Access to Document

Other files and links

Cite this